Michael Heming

Latest

• Alemtuzumab treatment exemplifies discordant immune effects of blood and cerebrospinal fluid in multiple sclerosis.
• Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy
• Supporting the differential diagnosis of connective tissue diseases with neurological involvement by blood and cerebrospinal fluid flow cytometry
• Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma
• High-dimensional investigation of the cerebrospinal fluid to explore and monitor CNS immune responses.
• Stroke induces disease-specific myeloid cells in the brain parenchyma and pia
• Intraocular dendritic cells characterize HLA-B27-associated acute anterior uveitis
• Bcl6 controls meningeal Th17-B cell interaction in murine neuroinflammation.
• Cerebrospinal fluid flow cytometry distinguishes psychosis spectrum disorders from differential diagnoses
• Single-cell profiling of CNS border compartment leukocytes reveals that B cells and their progenitors reside in non-diseased meninges.
• Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid
• Leukocyte profiles in blood and CSF distinguish neurosarcoidosis from multiple sclerosis
• Redefining the heterogeneity of peripheral nerve cells in health and autoimmunity.
• Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis
• Pretreatment anti-thyroid autoantibodies indicate increased risk for thyroid autoimmunity secondary to alemtuzumab: A prospective cohort study
• Immune cell profiling of the cerebrospinal fluid provides pathogenetic insights into inflammatory neuropathies
• Peroxisome Proliferator-Activated Receptor-γ Modulates the Response of Macrophages to Lipopolysaccharide and Glucocorticoids